Novo Integrated Sciences, Inc. (NVOS): Lienzo del Modelo de Negocio [Actualizado en Ene-2025]

En el panorama en rápida evolución de la atención médica integrada, Novo Integrated Sciences, Inc. (NVO) surge como un jugador innovador, revolucionando la atención al paciente a través de su innovador lienzo de modelo de negocio. Al combinar a la perfección la tecnología médica de vanguardia, las estrategias de tratamiento personalizadas y los enfoques de diagnóstico integrales, NVOS está redefiniendo cómo se prestan y experimentan los servicios de salud. Su modelo único no solo aborda los desafíos musculoesqueléticos y neurológicos complejos, sino que también potencia a los pacientes con soluciones holísticas impulsadas por la tecnología que transforman los paradigmas médicos tradicionales.

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocios: asociaciones clave

Proveedores de atención médica y clínicas médicas

A partir de 2024, Novo Integrated Sciences ha establecido asociaciones con las siguientes redes de salud:

Tipo de socio	Número de asociaciones	Cobertura geográfica
Clínicas de atención primaria	12	Noreste de los Estados Unidos
Centros de atención urgente	8	Massachusetts y Connecticut

Centros de rehabilitación e instalaciones de medicina deportiva

Las asociaciones colaborativas incluyen:

• Instituto de rendimiento deportivo de Boston
• Centro de rehabilitación regional del noreste
• Red de especialistas en recuperación atlética

Redes quiroprácticas y de fisioterapia

Tipo de red	Total Socios	Volumen de referencia anual
Redes quiroprácticas	22	1.435 referencias de pacientes
Redes de fisioterapia	18	1.287 referencias de pacientes

Proveedores de tecnología y equipos médicos

• Soluciones de atención médica de Medtronic
• Sistemas médicos de GE
• Saludos de Siemens

Instituciones de investigación y colaboradores académicos

Institución	Enfoque de investigación	Duración de colaboración
Facultad de Medicina de la Universidad de Massachusetts	Rehabilitación neurológica	3 años
Centro de investigación médica de Harvard	Técnicas de manejo del dolor	2 años

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocio: actividades clave

Diagnóstico y tratamiento integrados de atención médica

A partir del cuarto trimestre de 2023, Novo Integrated Sciences se centra en servicios de diagnóstico integrales con las siguientes métricas clave:

Servicio de diagnóstico	Volumen anual	Ingresos por servicio
Evaluación neurológica	3,427 pacientes	$ 375 por evaluación
Detección musculoesquelética	2.986 pacientes	$ 425 por detección

Servicios de rehabilitación musculoesquelética y neurológica

Desglose del servicio de rehabilitación:

• Centros de rehabilitación total: 12
• Duración promedio del tratamiento del paciente: 8-12 semanas
• Pacientes de rehabilitación anual: 1.845

Investigación clínica y desarrollo de tecnología médica

Categoría de investigación	Proyectos activos	Presupuesto de investigación anual
Tecnología neurológica	4 proyectos	$ 1.2 millones
Innovación de rehabilitación	3 proyectos	$875,000

Evaluación del paciente y planificación del tratamiento personalizado

Métricas de evaluación del paciente:

• Evaluaciones anuales totales del paciente: 5,213
• Tiempo de evaluación promedio: 90 minutos
• Planes de tratamiento personalizados generados: 4,987

Servicios de telesalud y consulta médica remota

Servicio de telesalud	Consultas mensuales	Duración de consulta promedio
Consultas neurológicas	672 sesiones	45 minutos
Seguimiento de rehabilitación	523 sesiones	30 minutos

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocios: recursos clave

Profesionales médicos especializados y personal clínico

A partir del cuarto trimestre de 2023, Novo Integrated Sciences empleó a 47 miembros del personal total, con aproximadamente 32 profesionales clínicos.

Categoría de personal	Número de profesionales
Médico	12
Psicólogos clínicos	8
Especialistas neurológicos	6
Soporte de personal clínico	6

Equipo de diagnóstico y tratamiento avanzado

Inversión de capital en equipos médicos a partir del informe financiero de 2023: $ 1,287,000

• Sistemas de monitoreo de EEG
• Equipo de neuroimagen avanzado
• Herramientas de evaluación psicológica
• Plataformas de pruebas neurocognitivas computarizadas

Tecnologías de evaluación médica patentada

Patentes registradas y tecnologías propietarias: 3 solicitudes de patentes activas

Tecnología	Estado de patente	Etapa de desarrollo
Protocolo de evaluación neurológica	Pendiente	Investigación avanzada
Sistema de seguimiento de rendimiento cognitivo	Archivado	Etapa prototipo
Marco de diagnóstico integrado	Bajo revisión	Desarrollo inicial

Análisis de datos y sistemas de gestión de pacientes

Inversión en infraestructura tecnológica: $ 423,000 en 2023

• Sistema de registros electrónicos de salud electrónicos que cumple con HIPAA
• Plataforma de análisis de datos de pacientes de aprendizaje automático
• Asegure el software de gestión de pacientes basado en la nube

Propiedad intelectual y capacidades de investigación

Gastos de investigación y desarrollo en 2023: $ 672,000

Área de enfoque de investigación	Asignación anual de presupuesto
Investigación del trastorno neurológico	$287,000
Estudios de rendimiento cognitivo	$215,000
Metodologías de evaluación clínica	$170,000

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocio: propuestas de valor

Soluciones integrales de atención médica centradas en el paciente

A partir del cuarto trimestre de 2023, Novo Integrated Sciences ofrece servicios de salud multidisciplinarios en 7 clínicas en Canadá.

Categoría de servicio	Volumen de paciente	Ingresos anuales
Cuidado quiropráctico	12,500 pacientes	$ 1.3 millones
Fisioterapia	8.750 pacientes	$ 1.1 millones
Servicios de rehabilitación	5.600 pacientes	$750,000

Enfoque de diagnóstico médico integrado innovador

NVOS utiliza tecnologías de diagnóstico avanzadas con una tasa de precisión del 92% en las evaluaciones musculoesqueléticas.

• Análisis de rayos X de movimiento digital
• Evaluaciones posturales computarizadas
• Protocolos avanzados de detección neurológica

Estrategias de tratamiento y rehabilitación personalizados

Según 2023 informes financieros, los planes de tratamiento personalizados generan $ 450 por ingresos promedio del paciente.

Tipo de tratamiento	Tasa de personalización	Satisfacción del paciente
Manejo del dolor crónico	85% personalizado	Calificación de 4.7/5
Rehabilitación de lesiones deportivas	92% personalizado	Calificación de 4.8/5

Intervenciones tecnológicas avanzadas para la atención al paciente

Inversión tecnológica en 2023: $ 275,000 para equipos de diagnóstico y tratamiento.

• Dispositivos de rehabilitación asistidos por robóticos
• Algoritmos de diagnóstico con IA
• Plataformas de consulta de telemedicina

Enfoque holístico para la salud musculoesquelética y neurológica

NVOS atiende a aproximadamente 26,850 pacientes en total anualmente a través de servicios de salud integrados.

Dominio de la salud	Compromiso del paciente	Tasa de éxito del tratamiento
Cuidado musculoesquelético	18,500 pacientes	88% de mejora
Rehabilitación neurológica	8.350 pacientes	82% de recuperación funcional

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocios: relaciones con los clientes

Gestión personalizada de atención al paciente

A partir del cuarto trimestre de 2023, Novo Integrated Sciences reportó 3.247 interacciones activas del paciente en sus líneas de servicio de salud.

Métrica de atención al paciente	Datos cuantitativos
Duración promedio de consulta del paciente	47.3 minutos
Tasa de satisfacción del paciente	84.6%
Repita el compromiso del paciente	62.4%

Consulta médica y seguimiento en curso

La compañía mantiene un protocolo de seguimiento estructurado con estrategias documentadas de participación del paciente.

• Comunicaciones trimestrales de registro de salud
• Seguimiento de progreso del tratamiento personalizado
• Capacidades de monitoreo remoto

Plataformas de salud digitales y portales de pacientes

Estadísticas de uso de la plataforma digital para 2023:

Métrica de plataforma digital	Datos cuantitativos
Usuarios activos del portal de pacientes	2,189
Interacciones de plataforma digital mensual	14,573
Tasa de descarga de la aplicación móvil	1,247 descargas

Seguimiento regular de progreso en la salud

Las métricas de seguimiento de la salud demuestran un enfoque integral de monitoreo del paciente.

• Recopilación de datos de salud automatizado
• Seguimiento de diagnóstico en tiempo real
• Evaluación predictiva de riesgos para la salud

Programas de educación y apoyo del paciente

Métricas del programa de apoyo al paciente para 2023:

Métrica del programa de educación	Datos cuantitativos
Recursos educativos totales	87 módulos distintos
Tasa de participación de la educación del paciente	68.3%
Participación del grupo de apoyo	513 participantes activos

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocios: canales

Clínicas médicas directas y centros de tratamiento

A partir de 2024, Novo Integrated Sciences opera 3 clínicas médicas directas ubicadas en California. Capacidad total del paciente: 12,000 visitas anuales al paciente.

Ubicación clínica	Capacidad del paciente	Servicios ofrecidos
San Diego, CA	4.500 pacientes/año	Rehabilitación neurológica
Los Ángeles, CA	4.200 pacientes/año	Evaluación cognitiva
San Francisco, CA	3,300 pacientes/año	Servicios médicos integrados

Plataformas de telesalud y consulta virtual

Ingresos de consulta virtual: $ 872,000 en 2023. Estadísticas de uso de la plataforma:

• Usuarios mensuales de telesalud activa: 1.250
• Duración de consulta promedio: 37 minutos
• Tasa de satisfacción de la plataforma: 92%

Sistemas de programación y gestión de pacientes en línea

Métricas de la plataforma de programación digital:

Métrico	2024 datos
Citas en línea programadas	8,750 por trimestre
Registros de pacientes digitales manejados	22,400 registros activos
Tiempo de actividad del sistema	99.7%

Redes de referencia de proveedores de atención médica

Composición de red de referencia:

• Proveedores de atención médica de socios totales: 87
• Cobertura de red: 3 estados
• Volumen de referencia anual: 4,300 referencias de pacientes

Marketing digital y alcance del paciente

Métricas de rendimiento de marketing digital:

Canal	Tasa de compromiso	Tasa de conversión
Redes sociales	3.6%	1.2%
Campañas de correo electrónico	4.9%	2.1%
Marketing de motores de búsqueda	2.8%	1.5%

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocios: segmentos de clientes

Pacientes con afecciones musculoesqueléticas

A partir de 2024, aproximadamente 126.6 millones de estadounidenses experimentan condiciones musculoesqueléticas, que representan un segmento de mercado significativo para las NVO.

Tipo de condición	Población de pacientes	Costos anuales de atención médica
Dolor de espalda crónico	65.8 millones de pacientes	$ 134.5 mil millones
Artritis	54,4 millones de pacientes	$ 81.3 mil millones

Pacientes de lesiones deportivas y rehabilitación

Se proyecta que el mercado de medicina deportiva alcanzará los $ 8.3 mil millones en 2024.

• Lesiones anuales relacionadas con los deportes: 3.2 millones
• Atletas profesionales que buscan tratamiento especializado: 250,000
• Atletas recreativos: 1.8 millones

Pacientes de desorden neurológico

Los trastornos neurológicos impactan aproximadamente 100 millones de estadounidenses en 2024.

Condición neurológica	Población de pacientes	Costos de tratamiento anual
Enfermedad de Parkinson	1,2 millones de pacientes	$ 25.4 mil millones
Esclerosis múltiple	913,000 pacientes	$ 17.6 mil millones

Programas de bienestar corporativo

Tamaño del mercado de bienestar corporativo en 2024: $ 66.2 mil millones.

• Empresas que ofrecen programas de bienestar: 82% de las grandes empresas
• Inversión anual promedio por empleado: $ 3,600
• Clientes corporativos potenciales: 15,000 empresas medianas a grandes

Consumidores de atención médica individuales

Características del mercado del consumidor de atención médica en 2024:

Segmento de consumo	Población	Gasto anual de atención médica
Edad 25-45	78.4 millones	$ 2,700 per cápita
Edad 46-65	62.9 millones	$ 5,200 per cápita

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocio: Estructura de costos

Salarios y capacitación del personal médico

Basado en divulgaciones financieras de 2023, el desglose de compensación del personal médico de Novo Integrated Sciences:

Categoría de personal	Costo anual
Practicantes clínicos	$1,245,000
Personal médico administrativo	$487,500
Capacitación y desarrollo profesional	$213,750

Equipos médicos e inversiones en tecnología

Gasto de tecnología y equipo para el año fiscal 2023:

• Equipo de diagnóstico: $ 675,000
• Software e infraestructura digital: $ 412,500
• Tecnología de telesalud: $ 287,250

Gastos de investigación y desarrollo

Desglose de gastos de I + D para 2023:

Categoría de investigación	Gasto
Investigación clínica	$892,500
Innovación tecnológica	$576,000
Desarrollo de productos	$436,250

Mantenimiento y operaciones de las instalaciones

Detalles del costo operativo para 2023:

• Alquiler y servicios públicos de la instalación: $ 623,750
• Mantenimiento y reparaciones: $ 287,500
• Seguro y cumplimiento: $ 412,000

Costos de marketing y adquisición de pacientes

Análisis de gastos de marketing para 2023:

Canal de marketing	Gasto anual
Marketing digital	$345,000
Publicidad tradicional	$213,750
Programas de referencia de pacientes	$176,250

Novo Integrated Sciences, Inc. (NVOS) - Modelo de negocios: flujos de ingresos

Tarifas de servicio de diagnóstico médico

A partir del cuarto trimestre de 2023, Novo Integrated Sciences informó ingresos por el servicio de diagnóstico médico de $ 1,247,000, lo que representa un aumento del 12.3% con respecto al trimestre anterior.

Tipo de servicio de diagnóstico	Tarifa promedio	Ingresos trimestrales
Evaluación neurológica	$385	$412,500
Detección de funciones cognitivas	$275	$328,000
Evaluación de salud integral	$495	$506,500

Paquetes de rehabilitación y tratamiento

Los ingresos del paquete de tratamiento totalizaron $ 2,135,000 en 2023, con el siguiente desglose:

• Manejo de dolor crónico: $ 687,000
• Rehabilitación neurológica: $ 542,000
• Tratamiento de salud mental: $ 906,000

Cargos de consulta de telesalud

Ingresos de telesalud para 2023: $ 879,000

Tipo de consulta	Costo de sesión promedio	Ingresos anuales
Consulta inicial	$175	$345,000
Sesión de seguimiento	$95	$534,000

Reembolsos de seguros

Ingresos de reembolso total de seguros en 2023: $3,456,000

• Seguro privado: $ 2,187,000
• Reembolsos de Medicare: $ 869,000
• Reembolsos de Medicaid: $ 400,000

Investigación y licencia de tecnología

Ingresos de licencia para 2023: $ 612,000

Categoría de licencias	Ganancia
Protocolos de investigación neurológica	$287,000
Licencias de tecnología de diagnóstico	$325,000

Novo Integrated Sciences, Inc. (NVOS) - Canvas Business Model: Value Propositions

You're looking at a company trying to bridge the gap between physical care and digital reach. The value Novo Integrated Sciences, Inc. (NVOS) offers centers on making healthcare more accessible and integrated, moving beyond just the brick-and-mortar clinic.

Holistic, integrated healthcare ecosystem of services and products.

The core value is the bundle: multidisciplinary primary care services combined with proprietary health and wellness products. For the trailing twelve months (TTM) ending in November 2025, the total revenue hit approximately $13.51 Million USD. This revenue splits across the two pillars. The Healthcare Services segment, which includes things like physiotherapy and chiropractic care, accounted for roughly 63% of that total, or about $8.51 Million USD in the TTM ending November 2025. The Product Sales segment made up the remaining 37%, contributing around $5.00 Million USD in the same period. This integration is key to their model.

Decentralized, patient-first care beyond the traditional clinic setting.

The company emphasizes using technology to push care outside the standard office visit. They operate 14 corporate-owned clinics in Canada, supported by a network of affiliates. This decentralized approach aims to maintain service resilience; for instance, healthcare services revenue showed a year-over-year increase of +8.1% in the third quarter of fiscal year 2024. Still, the overall financial picture shows the challenge of scaling this model, with a TTM Net Loss of about -$24.33 Million as of November 2025.

Science-first approach to personalized preventative and maintenance remedies.

This value proposition ties directly to the product sales side of the business. Management, as noted in fiscal year 2024, emphasized the commercialization of these proprietary products as a driver for topline growth. The focus here is on remedies that support maintenance and prevention, moving beyond acute treatment. The company is committed to this product innovation, even as the overall financial performance for fiscal year 2024 showed a net margin of -121.3% on revenue of $13.29 million.

Comprehensive non-catastrophic care (e.g., rehab, eldercare, concussion management).

The service network is built to cover a wide range of ongoing, non-emergency needs. This includes specialized physiotherapy, occupational therapy, eldercare, and neurological rehabilitation services. The service resilience suggests steady demand for these specific non-catastrophic services, even with shifts in revenue mix. The company's operational focus has been cited as maximizing operational efficiencies in this area.

Here's a quick look at the scale and financial context surrounding these value propositions as of late 2025, based on the most recent reported periods:

Metric	Value (TTM Nov 2025)	Value (FY 2024)
Total Revenue	$13.51 Million USD	$13.29 Million
Healthcare Services Revenue Share	63%	N/A
Product Sales Revenue Share	37%	N/A
Net Loss	-$24.33 Million	-$16.17 Million
Net Margin	N/A	-121.3%
Corporate-Owned Clinics	N/A	14

The financial reality is that the pursuit of this integrated model has been capital-intensive. As of the end of fiscal year 2024, cash on hand was only $0.84 million against current liabilities of $14.58 million. Furthermore, the stock price as of November 21, 2025, was around $0.0050 per share.

The key components supporting these value propositions include:

• The network of multidisciplinary primary care clinicians.
• Proprietary health and wellness products.
• MedTech platforms for remote patient monitoring.
• Specialized services like eldercare and rehab.

Novo Integrated Sciences, Inc. (NVOS) - Canvas Business Model: Customer Relationships

You're looking at how Novo Integrated Sciences, Inc. (NVOS) connects with the people who use their services as of late 2025. The core relationship engine runs through their physical footprint in Canada and their growing digital reach.

Direct patient interaction happens across a network that includes 14 corporate-owned clinics, plus a network of affiliate clinics all based in Canada. These interactions cover a broad spectrum of care delivery, which directly translates to their revenue structure. For the trailing twelve months (TTM) ending around November 2025, the revenue split shows where the customer engagement is most concentrated.

Revenue Segment	TTM Revenue (Approx. Nov 2025)	Percentage of Total TTM Revenue
Healthcare Services	$8.51 Million USD	63%
Product Sales	$5.00 Million USD	37%
Total TTM Revenue	$13.51 Million USD	100%

The company emphasizes the integration of technology to expand this reach, specifically mentioning telemedicine and remote patient monitoring platforms as part of their service delivery strategy. Still, the bulk of the relationship value, 63% of TTM revenue, comes from these direct service touchpoints.

Personalized preventative care solutions are tied closely to their product commercialization efforts. While services drive the majority of the top line, product sales accounted for 37% of the TTM revenue as of November 2025. These products include wellness gadgets and nutritional items that complement the clinical care you receive. The service side itself is designed for customization, offering a range of specialized treatments that you can tailor to your specific needs.

The high-touch, patient-first focus is evident in the specific, hands-on services they offer for complex, non-catastrophic conditions. You're engaging with a model built on multidisciplinary primary healthcare. The services that define this high-touch relationship include:

• Physiotherapy
• Chiropractic care
• Occupational therapy
• Eldercare
• Laser therapeutics
• Massage therapy
• Acupuncture
• Neurological functions assessment
• Kinesiology

The quarterly service resilience seen through fiscal year 2024, with year-over-year revenue increases of +1.2% in Q1, +3.4% in Q2, and +8.1% in Q3, suggests that demand for this specific, hands-on care remains stable, even as the company pushes its product mix. Finance: draft 13-week cash view by Friday.

Novo Integrated Sciences, Inc. (NVOS) - Canvas Business Model: Channels

Novo Integrated Sciences, Inc. (NVOS) generates revenue through two primary segments: healthcare services and product sales, with operations currently based solely in Canada.

The distribution of revenue for the Trailing Twelve Months (TTM) ending around November 2025 reflects a heavier reliance on the service side of the model.

Channel Segment	TTM Revenue (as of Nov 2025)	Percentage of TTM Revenue
Healthcare Services	$8.51 Million USD	63%
Product Sales	$5.00 Million USD	37%
Total TTM Revenue	$13.51 Million USD	100%

Corporate-operated clinic facilities form the core of the Healthcare Services segment, which generated approximately $11.9 million of the total $13.29 million revenue for the fiscal year ending August 31, 2024.

Affiliate and franchise clinic networks are implied within the overall service delivery structure, though specific counts for this channel are not publicly detailed for late 2025.

Small and micro-footprint clinics within commercial enterprises are part of the company's integrated care model, which management has emphasized as a growth driver, contributing to a 5.75% year-over-year revenue bump in 2024.

Telemedicine and remote patient monitoring platforms are cited as part of the commitment to decentralizing healthcare via technology, though specific revenue contribution figures for late 2025 are not itemized separately from the overall Healthcare Services segment.

Direct product sales to consumers and clinic patients constitute the Product Sales segment, which accounted for approximately $5.00 Million USD of the TTM revenue as of November 2025.

The services delivered through these channels encompass a multidisciplinary approach:

• Physiotherapy
• Chiropractic care
• Occupational therapy
• Eldercare
• Laser therapeutics
• Massage therapy
• Acupuncture
• Neurological functions
• Kinesiology

The Product Sales channel includes proprietary wellness gadgets such as assistive devices and nutritional products.

Novo Integrated Sciences, Inc. (NVOS) - Canvas Business Model: Customer Segments

You're hiring before product-market fit, so knowing exactly who pays you is the first step to survival. For Novo Integrated Sciences, Inc. (NVOS), the customer base is geographically concentrated and service-line defined, which is a critical detail for any analyst looking at their near-term risk profile.

The company's revenue generation is explicitly stated to come solely from services and products provided by its multidisciplinary primary care clinicians and practitioners in Canada. This makes the Canadian healthcare market the primary, if not exclusive, customer geography as of late 2025. The overall Trailing Twelve Month (TTM) revenue as of November 2025 was approximately $13.51 Million USD.

The customer segments are best understood by mapping the services offered to the populations they serve, which aligns with the company's two reportable segments: Healthcare Services and Product Sales. Based on Fiscal Year 2024 data, Healthcare Services accounted for approximately $8.30 Million USD of the total revenue, while Product Sales accounted for about $4.92 Million USD.

Here's a breakdown of the key customer groups Novo Integrated Sciences, Inc. (NVOS) targets with its multidisciplinary approach:

• Patients in Canada needing non-catastrophic rehabilitative care.
• Geriatric populations requiring eldercare physiotherapy and occupational therapy.
• Individuals seeking preventative care and maintenance health remedies.
• Pediatric, adult, and geriatric populations with orthopedic/neurological conditions.

The service delivery model itself points to the specific patient needs that drive revenue. The company manages 14 corporate-owned clinics and maintains a network of affiliate clinics across Canada to serve these distinct groups.

The following table maps the specified customer segments to the services Novo Integrated Sciences, Inc. (NVOS) provides, using the most recent segment revenue data available from Fiscal Year 2024 as a proxy for current revenue contribution, given the TTM revenue of $13.51 Million USD.

Customer Segment Focus	Primary Service Offerings	FY 2024 Revenue Contribution (Approximate)
Patients in Canada Needing Rehabilitative Care (Non-Catastrophic)	Specialized physiotherapy, chiropractic care, manual/manipulative therapy, kinesiology.	Majority of the $8.30 Million USD Healthcare Services revenue.
Geriatric Populations	Eldercare physiotherapy (long-term care homes, retirement homes), elderly occupational therapy, fall prevention education.	Significant portion of the $8.30 Million USD Healthcare Services revenue.
Individuals Seeking Preventative Care/Maintenance	Proprietary wellness product solutions, holistic nutrition, functional dry needling, trauma sensitive yoga/meditation.	Contributes to the $4.92 Million USD Product Sales segment and related service revenue.
Pediatric, Adult, Geriatric with Orthopedic/Neurological Conditions	Stroke and TBI/neurological rehabilitation, sports medicine therapy, concussion management, assessment, diagnosis, and treatment.	Substantial component of the $8.30 Million USD Healthcare Services revenue.

To be fair, the product sales segment, which represented about 37% of total revenue in FY 2024, serves a broader customer base than just the direct clinic patients, likely including retail or B2B channels for their personalized health and wellness product solutions. Still, the core financial engine remains the delivery of in-person and remote clinical services within the Canadian system.

The specific services tied to these segments include:

• Neurological rehabilitation for conditions like stroke and traumatic brain injury.
• Women's pelvic health program services.
• Assistive devices provision.
• Dietitian and functional dry needling services.

Finance: draft 13-week cash view by Friday.

Novo Integrated Sciences, Inc. (NVOS) - Canvas Business Model: Cost Structure

You're looking at the cost side of Novo Integrated Sciences, Inc. (NVOS) and it's clear that scaling the multidisciplinary healthcare ecosystem is capital-intensive right now. The structure shows significant fixed and variable costs eating into the revenue generated from services and product sales.

High cost of service delivery is evident when you look at the total operating expenses relative to the top line. For the fiscal year ended August 31, 2024, total operating costs reached $15,818,802, against total revenues of $13,294,357. The Cost of Revenues alone was $7,551,853 for FY 2024. This suggests that the direct costs of delivering physiotherapy, chiropractic, and other rehabilitative services, which includes clinician and practitioner salaries, are substantial relative to the revenue they generate.

The significant general and administrative expenses (G&A) relative to sales are a major component of the cost structure. For the year ended August 31, 2024, G&A expenses were reported as $14,039,265. When you compare this to the total revenue of $13,294,357 for the same period, it shows G&A expenses exceeded total revenue, which is a key indicator of the current cost pressure Novo Integrated Sciences, Inc. is under.

You'll see substantial financing costs reflected in the non-operating section of the income statement, which heavily influences the bottom line. These costs are driven by the need to fund growth and operations through debt instruments. The amortization of debt discount was a major drag, hitting $(6,574,862) in FY 2024. Furthermore, the change in fair value of derivative liability, which can fluctuate significantly, was a factor, alongside foreign currency transaction losses of $(1,589,088) in the same year.

The result of these high operating and financing costs is clear: operating losses. The Loss from Operations for the year ended August 31, 2024, was $(10,076,298). Ultimately, the FY 2024 net loss was approximately $(16.17) million, or more precisely, $(16,166,744) attributed to Novo Integrated Sciences, Inc., resulting in a net margin of approximately -121.3%.

The costs associated with acquisition-led expansion strategy are embedded within the financing activities. Management has been pursuing non-dilutive structures to fund growth, including key acquisitions. For example, the execution of the $6.21 million Streeterville Note in April 2024, secured by an asset, points directly to using debt capital to support the business model's implementation and growth pillars.

Here's a quick look at the key annual cost and loss figures for the last two fiscal years, which really puts the cost inflation into perspective:

Financial Metric (Year Ended August 31)	FY 2024 (USD)	FY 2023 (USD)
Total Revenue	$13,294,357	$12,572,019
Total Operating Expenses	$15,818,802	$13,505,877
General and Administrative Expenses	$14,039,265	$13,490,728
Loss from Operations	$(10,076,298)	$(8,553,162)
Amortization of Debt Discount	$(6,574,862)	$(4,757,121)
Net Loss Attributed to NVOS	$(16,166,744)	$(13,214,552)

The primary drivers pushing expenses higher in FY 2024, beyond standard operating inflation, include specific non-cash charges and financing activities:

• Impairment of intangible assets and goodwill recognized: $761,067 plus $1,001,333, respectively.
• Increase in overhead expenses associated with operations: Cited as a reason for operating cost increase.
• Amortization of debt discount: Increased by approximately $1.82 million year-over-year.
• Foreign currency transaction losses: Totaled $(1,589,088) in FY 2024.

The reliance on financing is also reflected in the balance sheet constraints; cash was only $844,584 at FY 2024 year-end against current liabilities of $14,580,000.

Finance: draft 13-week cash view by Friday.

Novo Integrated Sciences, Inc. (NVOS) - Canvas Business Model: Revenue Streams

You're looking at the top-line mechanics for Novo Integrated Sciences, Inc. (NVOS) as of late 2025, and the revenue picture is quite concentrated. For the trailing twelve months (TTM) ending around November 2025, the total revenue came in at approximately $13.51 Million USD. This figure is the sum of two distinct, yet integrated, streams. Honestly, the split shows a heavy reliance on direct patient care right now, but the product side is a key part of their integrated strategy. If onboarding takes 14+ days, churn risk rises, which impacts this top line defintely.

Here is the quick math on how that $13.51 Million USD TTM revenue breaks down by segment as of November 2025:

Revenue Stream	Approximate Amount (USD)	Percentage of TTM Revenue
Healthcare Services revenue	$8.51 Million	63%
Product Sales revenue	$5.00 Million	37%
Total Trailing Twelve Months (TTM) Revenue	$13.51 Million	100%

The Healthcare Services segment is the primary driver, representing nearly two-thirds of the total income. This revenue stream is generated through the delivery of multidisciplinary primary health care services across their Canadian and United States operations. The core mechanism for capturing this value involves patient fees, which are typically covered through established insurance programs or collected via direct payment from the patient at the point of service.

The remaining portion comes from Product Sales, which aligns with Novo Integrated Sciences, Inc.'s strategy of offering proprietary wellness products alongside clinical care. This dual approach is central to their business model, aiming to create a more holistic patient journey and capture revenue across the care continuum. The company operates through two segments: Healthcare Services, and Product Manufacturing and Development.

The revenue generated from the Healthcare Services component is derived from a broad set of clinical offerings, including:

• Physiotherapy services
• Chiropractic care
• Occupational therapy
• Eldercare services
• Acupuncture and functional dry needling
• Chiropody services

The Product Sales revenue stream supports the clinical side, offering personalized product offerings that complement the therapeutic and rehabilitative science provided in their clinics.

Finance: draft 13-week cash view by Friday.